期刊文献+

ELISA法检测麻疹病毒IgM抗体血清外对照的设置及意义 被引量:4

Value of extra serum control in ELISA for measles virus IgM antibody detection
下载PDF
导出
摘要 目的 为了严格控制麻疹IgM抗体ELISA检澳6试剂的质量,消除试剂误差产生的检测错误。方法 根据麻疹IgM抗体定量测定结果,选择标准曲线线性良好部分血清标本制备外对照血清,并计算出外对照血清对于相应公司试剂的参考值范围。结果实验测得外对照血清的活性为48.2~60.5Units/ml,对于海泰公司试剂的OD参考值范围是0.630~0.674。用此外对照血清对2个公司共5个批号的试剂盒做复核验证,发现海泰公司批号为20040806试剂盒检测结果失控,而正是此批号试剂对116份血清标本的检测阳性率和符合率明显低于其它试剂盒。还验证了此外对照血清的有效活性在4℃条件下可至少维持6个月。结论对于只有阴/阳性定性指示的ELISA检测试剂盒,制备特定OD值范围的外对照质控血清很有必要。 Objective To accurately control the quality of measles virus IgM ELISA kits and eliminate the false results caused by reagents. Methods Based on measles virus IgM quantification, standardized extra control serum was selected from the scale of standard curve with good linearity and its referential value was measured by kit of certain company. Results The biological activity of extra control serum was 48.2 - 60.5 uits/ml, and its OD referential range measured by the kit of "Hai Tai" company was 0. 630 ~ 0. 674. Through the usage of extra control serum in 116 samples'detection by kits of 5 batches from 2 companies,we found that the batch 20040806 kit of " Hai Tai" not only lost control,but also showed lower positive and coincident rate in contrast to others.The activity of extra control serum could be maintained at least for 6 months at 4℃. Conclusion It is necessary to prepare extra control serum with definite OD range from those measles virus IgM ELISA kits only having qualitative referential positive/negative serum.
出处 《应用预防医学》 2006年第4期201-203,共3页 Applied Preventive Medicine
基金 广西壮族自治区疾病预防控制中心资助项目 合同编号:20030010
关键词 ELISA 麻疹病毒 IGM抗体 血清外对照 ELISA Measles virus IgM antibody Extra serum control
  • 相关文献

参考文献2

二级参考文献8

  • 1许文波,张礼璧,夏亭海,胡湖,唐蕊妍,祝双利,蒋泓,安洪秋,小船富美夫.麻疹野病毒的分离及血清学的初步分析[J].中国计划免疫,1996,2(1):4-7. 被引量:44
  • 2WHO. Standardization of the nomenclature for describing the genetic characteristics of wild - type measles viruses[ J ]. WER, 1998, 73:265 - 272.
  • 3WHO. Nomenclature for describing the genetic characteristics of wild - type measles viruses ( update ) [ J ] . WER, 2001, 76: 241-247.
  • 4WHO. Nomenclature for describing the genetic characteristics of wild - type measles viruses(update) Part Ⅱ[J ]. WER, 2001,76: 249 -251.
  • 5CDC. Progress toward interrupting indigenous measles transmission, region of the Americas, January - November 2001 [ J ] . MMWR, 2001,50:1133 - 1137.
  • 6Sato T A, Miyamura K, Sakae K.Development of a gelatin particleagglutination reagent for measles antibody assay [J ] .Arch Virol, 1997,142(10) : 1971 - 1977.
  • 7Global Programme for Vaccines and Immunization, Expanded Programme on Immunization, WHO. Manual for the laboratory diagnosis of measles virus infection[S] ,24 Feb, 1999.
  • 8许文波.麻疹病毒的分子流行病学[J].中国计划免疫,2001,7(1):54-59. 被引量:107

共引文献11

同被引文献44

引证文献4

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部